Literature DB >> 7959693

Genetic heterogeneity in hypokalemic periodic paralysis (hypoPP).

E Plassart1, A Elbaz, J V Santos, J Reboul, P Lapie, D Chauveau, K Jurkat-Rott, J Guimaraes, J M Saudubray, J Weissenbach.   

Abstract

Hypokalemic periodic paralysis (hypoPP) is an autosomal dominant disorder belonging to a group of muscle diseases known to involve an abnormal function of ion channels. The latter includes hypokalemic and hyperkalemic periodic paralyses, and non-dystrophic myotonias. We recently showed genetic linkage of hypoPP to loci on chromosome 1q31-32, co-localized with the DHP-sensitive calcium channel CACNL1A3. We propose to term this locus hypoPP-1. Using extended haplotypes with new markers located on chromosome 1q31-32, we now report the detailed mapping of hypoPP-1 within a 7 cM interval. Two recombinants between hypoPP-1 and the flanking markers D1S413 and D1S510 should help to reduce further the hypoPP-1 interval. We used this new information to demonstrate that a large family of French origin displaying hypoPP is not genetically linked to hypoPP-1. We excluded genetic linkage over the entire hypoPP-1 interval showing for the first time genetic heterogeneity in hypoPP.

Entities:  

Mesh:

Year:  1994        PMID: 7959693     DOI: 10.1007/BF00211025

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  33 in total

Review 1.  DNA polymorphism and human disease.

Authors:  J F Gusella
Journal:  Annu Rev Biochem       Date:  1986       Impact factor: 23.643

2.  Molecular genetic and genetic correlations in sodium channelopathies: lack of founder effect and evidence for a second gene.

Authors:  J Wang; J Zhou; S M Todorovic; W G Feero; F Barany; R Conwit; I Hausmanowa-Petrusewicz; A Fidzianska; K Arahata; H B Wessel
Journal:  Am J Hum Genet       Date:  1993-06       Impact factor: 11.025

3.  Evidence for genetic homogeneity in autosomal recessive generalised myotonia (Becker).

Authors:  M C Koch; K Ricker; M Otto; F Wolf; B Zoll; C Lorenz; K Steinmeyer; T J Jentsch
Journal:  J Med Genet       Date:  1993-11       Impact factor: 6.318

4.  Hyperkalemic periodic paralysis and the adult muscle sodium channel alpha-subunit gene.

Authors:  B Fontaine; T S Khurana; E P Hoffman; G A Bruns; J L Haines; J A Trofatter; M P Hanson; J Rich; H McFarlane; D M Yasek
Journal:  Science       Date:  1990-11-16       Impact factor: 47.728

5.  Permanent muscle weakness in familial hypokalaemic periodic paralysis. Clinical, radiological and pathological aspects.

Authors:  T P Links; M J Zwarts; J T Wilmink; W M Molenaar; H J Oosterhuis
Journal:  Brain       Date:  1990-12       Impact factor: 13.501

6.  Exclusion of linkage between hypokalemic periodic paralysis (HOKPP) and three candidate loci.

Authors:  W L Casley; M Allon; H K Cousin; S S Ting; M A Crackower; L Hashimoto; F Cornélis; J S Beckmann; A J Hudson; G C Ebers
Journal:  Genomics       Date:  1992-10       Impact factor: 5.736

7.  Linkage of Thomsen disease to the T-cell-receptor beta (TCRB) locus on chromosome 7q35.

Authors:  J A Abdalla; W L Casley; H K Cousin; A J Hudson; E G Murphy; F C Cornélis; L Hashimoto; G C Ebers
Journal:  Am J Hum Genet       Date:  1992-09       Impact factor: 11.025

8.  Adynamia episodica hereditaria with myotonia: a non-inactivating sodium current and the effect of extracellular pH.

Authors:  F Lehmann-Horn; G Küther; K Ricker; P Grafe; K Ballanyi; R Rüdel
Journal:  Muscle Nerve       Date:  1987-05       Impact factor: 3.217

9.  A cysteine-for-arginine substitution (R614C) in the human skeletal muscle calcium release channel cosegregates with malignant hyperthermia.

Authors:  K Hogan; F Couch; P A Powers; R G Gregg
Journal:  Anesth Analg       Date:  1992-09       Impact factor: 5.108

10.  Molecular basis of Thomsen's disease (autosomal dominant myotonia congenita).

Authors:  A L George; M A Crackower; J A Abdalla; A J Hudson; G C Ebers
Journal:  Nat Genet       Date:  1993-04       Impact factor: 38.330

View more
  4 in total

Review 1.  Genetic analysis of voltage-dependent calcium channels.

Authors:  C F Fletcher; N G Copeland; N A Jenkins
Journal:  J Bioenerg Biomembr       Date:  1998-08       Impact factor: 2.945

2.  Voltage-sensor sodium channel mutations cause hypokalemic periodic paralysis type 2 by enhanced inactivation and reduced current.

Authors:  K Jurkat-Rott; N Mitrovic; C Hang; A Kouzmekine; P Iaizzo; J Herzog; H Lerche; S Nicole; J Vale-Santos; D Chauveau; B Fontaine; F Lehmann-Horn
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-15       Impact factor: 11.205

3.  Hypokalemic periodic paralysis and the dihydropyridine receptor (CACNL1A3): genotype/phenotype correlations for two predominant mutations and evidence for the absence of a founder effect in 16 caucasian families.

Authors:  A Elbaz; J Vale-Santos; K Jurkat-Rott; P Lapie; R A Ophoff; B Bady; T P Links; C Piussan; A Vila; N Monnier
Journal:  Am J Hum Genet       Date:  1995-02       Impact factor: 11.025

Review 4.  Skeletal Muscle Channelopathies.

Authors:  Lauren Phillips; Jaya R Trivedi
Journal:  Neurotherapeutics       Date:  2018-10       Impact factor: 7.620

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.